Sectoral Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Sectoral Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-24,400	Closed	-$252K	–	137
2020 Q2	$252K	Buy	+24,400	New	+$250K	0.02%	168
2018 Q4	–	Sell	-18,388	Closed	-$284K	–	120
2018 Q3	$284K	Buy	+18,388	New	+$291K	0.03%	113
2016 Q2	–	Sell	-12,806	Closed	-$117K	–	71
2016 Q1	$117K	Sell	12,806 -84,818	-87%	-$700K	0.01%	81
2015 Q4	$948K	Buy	+97,624	New	+$944K	0.04%	71
2014 Q3	–	Sell	-430,704	Closed	-$5.53M	–	69
2014 Q2	$5.53M	Sell	430,704 -5,112,061	-92%	-$55.6M	0.23%	55
2014 Q1	$57.2M	Sell	5,542,765 -528,724	-9%	-$5.94M	2.35%	19
2013 Q4	$59M	Buy	6,071,489 +340,470	+6%	+$3.06M	2.55%	14
2013 Q3	$56.8M	Sell	5,731,019 -346,497	-6%	-$3.4M	2.73%	13
2013 Q2	$50.5M	Buy	+6,077,516	New	+$73.7M	1.49%	28

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Sectoral Asset Management's IRWD Position: Q3 2020 in Review

Sectoral Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 24,400 shares — an estimated $252K sold.

Sectoral Asset Management first reported a position in IRWD in Q2 2013 and held it in 9 quarters. The position peaked at $59M in Q4 2013. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

Sectoral Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Sectoral Asset Management sold 24,400 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $252K.
Sectoral Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Sectoral Asset Management's Ironwood Pharmaceuticals position peaked at $59M in Q4 2013.
190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.